Distribuidora Lagunera del Norte’s weper hand sanitizer, labeled 70% ethanol, tested at 28% and was refused at the U.S. border.
What happened
FDA tested a batch of weper Clean Solutions Hand Sanitizer that was detained and refused admission at the U.S. border. The product was labeled to contain 70% ethanol, but FDA found an average of only 28% v/v ethanol. FDA also cited it as an unapproved new drug and misbranded, and placed all drugs made by the firm on Import Alert 66-78 on March 10, 2021.
What FDA found
A batch labeled to contain 70% ethanol contained an average of only 28% v/v ethanol, so its strength was below what the label claimed.
FD&C Act section 501(c), 21 U.S.C. 351(c)The low ethanol level shows the firm’s quality assurance was not working under CGMP.
FD&C Act section 501(a)(2)(B), 21 U.S.C. 351(a)(2)(B)The hand sanitizer was an unapproved new drug because it was not generally recognized as safe and effective and had no FDA-approved application.
FD&C Act section 505(a), 21 U.S.C. 355(a); section 301(d), 21 U.S.C. 331(d)The label was false or misleading because it claimed 70% ethanol and displayed an FDA logo above the NDC number, suggesting FDA approval.
FD&C Act section 502(a), 21 U.S.C. 352(a); 21 CFR 207.77(b)The product label lacked the required Drug Facts panel.
FD&C Act section 502(c), 21 U.S.C. 352(c); 21 CFR 201.66The product was misbranded because it is a nonprescription drug subject to section 505G but did not meet that section’s marketing requirements and had no approved application.
FD&C Act section 502(ee), 21 U.S.C. 352(ee); section 505G, 21 U.S.C. 355h
What FDA wants
FDA asks the company to respond in writing within 15 working days, explaining how the labeled 70% product contained 28% ethanol, listing raw materials and suppliers and U.S.-shipped batches with reconciliation and batch records, and describing corrective actions to prevent recurrence. FDA also recommends a qualified CGMP consultant.
Who should pay attention
- clinics and doctor’s offices that buy hand sanitizer
- U.S. importers and distributors of foreign drug products
- manufacturers and brands relying on labeled alcohol content
This is a summary. Read the original letter on fda.gov.